Biotech Gainers: Ignyta Inc (NASDAQ:RXDX), Onconova Therapeutics Inc (NASDAQ:ONTX), Cempra Inc (NASDAQ:CEMP), ANI Pharmaceuticals Inc (NASDAQ:ANIP)

Ignyta Inc (NASDAQ:RXDX) released its earnings data. The company reported ($0.28) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.37) by $0.09. Finally, analysts at Ladenburg Thalmann initiated coverage on shares of company in a research note on Monday, March 24th. They set a “buy” rating and a $20.00 price target on the stock. Ignyta Inc (NASDAQ:RXDX) stock performance was 13.12% in last session and finished the day at $7.24. Traded volume was 54,641.00million shares in the last session and the average volume of the stock remained 101.16K shares.

Onconova Therapeutics Inc (NASDAQ:ONTX) posted its quarterly earnings results on 12 May 2014. The company reported ($0.87) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.78) by $0.09, Stock Ratings reports. Finally, analysts at Piper Jaffray downgraded shares of the company from an “overweight” rating to a “neutral” rating in a research note on Thursday, February 20th. They now have a $9.00 price target on the stock, down previously from $38.00. Onconova Therapeutics Inc (NASDAQ:ONTX) rose 5.57 percent to $5.12 Thursday on volume of 108,220.00million shares. The intra-day range of the stock was $4.85 to $5.12. has a market capitalization of $110.80million.

Cempra Inc (NASDAQ:CEMP) Director John Johnson acquired 10,000 shares of the company’s stock in a transaction that occurred on Friday, May 23rd. The stock was purchased at an average price of $9.10 per share, with a total value of $91,000.00. Following the transaction, the director now directly owns 10,000 shares of the company’s stock, valued at approximately $91,000. Cempra Inc (NASDAQ:CEMP)’s stock on May 29, 2014 reported a increase of 5.81% to the closing price of $9.66. Its fifty two weeks range is $6.95 -$15.38. The total market capitalization recorded $320.73million. The overall volume in the last trading session was 247,327.00million shares. In its share capital, CEMP has 33.20million outstanding shares.

A better-ranked stock in the pharma sector is ANI Pharmaceuticals, Inc. (NASDAQ:ANIP), carrying a Zacks Rank #1 (Strong Buy). On Thursday, shares of ANI Pharmaceuticals Inc (NASDAQ:ANIP) advanced 5.99% to close the day at $32.76. Company return on investment (ROI) is 2.20% and its monthly performance is recorded as 4.93%. ANI Pharmaceuticals Inc (NASDAQ:ANIP) quarterly revenue growth is 0.09%.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone